1 min
Pharmaceutical company Janssen applied on Tuesday to the European Medicines Agency (EMA) for the authorization of its single-dose vaccine. If the usual deadlines are met, a fourth covid vaccine could be available in the EU by the end of the month or in the first week of March at the latest.
